Journal of Community Health

, Volume 41, Issue 4, pp 864–870 | Cite as

Timeliness of Colonoscopy After Abnormal Fecal Test Results in a Safety Net Practice

  • Ann OluloroEmail author
  • Amanda F. Petrik
  • Ann Turner
  • Tanya Kapka
  • Jennifer Rivelli
  • Patricia A. Carney
  • Somnath Saha
  • Gloria D. Coronado
Original Paper


Fecal testing can only reduce colorectal cancer mortality if patients with an abnormal test result receive a follow-up colonoscopy. As part of the Strategies and Opportunities to STOP Colon Cancer in Priority Populations (STOP CRC) project, we examined factors associated with adherence to follow-up colonoscopy among patients with abnormal fecal test results. As part of STOP CRC outreach, Virginia Garcia Memorial Health Center staff distributed 1753 fecal immunochemical tests (FIT), of which 677 (39 %) were completed, and 56 had an abnormal result (8 %). Project staff used logistic regression analyses to examine factors associated with colonoscopy referral and completion. Of the 56 patients with abnormal FIT results; 45 (80 %) had evidence of a referral for colonoscopy, 32 (57 %) had evidence of a completed colonoscopy within 18 months, and 14 (25 %) within 60 days of an abnormal fecal test result. In adjusted analysis, Hispanics had lower odds of completing follow-up colonoscopy within 60 days than non-Hispanic whites (adjusted OR 0.20; 95 % CI 0.04, 0.92). Colonoscopy within 60 days trended lower for women than for men (adjusted OR 0.25; 95 % CI 0.06–1.04). Among the 24 patients lacking medical record evidence of a colonoscopy, 19 (79 %) had a documented reason, including clinician did not pursue, patient refused, and colonoscopy not indicated. No reason was found for 21 %. Improvements are needed to increase rates of follow-up colonoscopy completion, especially among female and Hispanic patients.


Colorectal cancer Federally qualified health center Hispanic/Latino Colonoscopy Gastroenterology referral 



Research reported in this publication was supported by the National Institutes of Health through the National Center for Complementary &Alternative Medicine under Award Number UH2AT007782 and the National Cancer Institute under Award Number 4UH3CA188640-02. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center for Complementary & Alternative Medicine or the National Cancer Institute. Dr. Saha’s contribution to this work was supported with resources and the use of facilities at the VA Portland Health Care System.

Compliance with Ethical Standards

Conflict of interest

The authors declare no conflict of interest.


  1. 1.
    US Preventive Services Task Force. (2008). Screening for colorectal cancer, Topic page. Accessed 5 Nov 2014.
  2. 2.
    Centers for Disease Control and Prevention. (2013). Awareness of prediabetes—United States, 2005–2010. Morbidity and Mortality Weekly Report (MMWR), 62(11), 209–212.Google Scholar
  3. 3.
    Wang, J., Moehring, J., Stuhr, S., & Krug, M. (2013). Barriers to colorectal cancer screening in Hispanics in the United States: An integrative review. Applied Nursing Research, 26(4), 218–224.CrossRefPubMedGoogle Scholar
  4. 4.
    Otiniano, M. E., Wood, R. C., Poursani, R. S., Katerndahl, D. A., Siddiqui, S., & Nadeau, M. T. (2013). Association of knowledge, attitudes, and behaviors for colon cancer screening in Hispanic patients. Ethnicity and Disease, 23(3), 343–348.PubMedGoogle Scholar
  5. 5.
    Johnson-Kozlow, M., Roussos, S., Rovniak, L., & Hovell, M. (2009). Colorectal cancer test use among Californians of Mexican origin: Influence of language barriers. Ethnicity and Disease, 19(3), 315–322.PubMedPubMedCentralGoogle Scholar
  6. 6.
    Day, L. W., Bhuket, T., & Allison, J. (2013). FIT testing: An overview. Current Gastroenterology Reports, 15(11), 357.CrossRefPubMedGoogle Scholar
  7. 7.
    Hernandez, V., Cubiella, J., Gonzalez-Mao, M. C., Iglesias, F., Rivera, C., Iglesias, M. B., et al. (2014). Fecal immunochemical test accuracy in average-risk colorectal cancer screening. World Journal of Gastroenterology, 20(4), 1038–1047.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Singh, H., Petersen, L. A., Daci, K., Collins, C., Khan, M., & El-Serag, H. B. (2010). Reducing referral delays in colorectal cancer diagnosis: Is it about how you ask? Quality and Safety in Health Care, 19(5), e27.PubMedGoogle Scholar
  9. 9.
    Powell, A. A., Nugent, S., Ordin, D. L., Noorbaloochi, S., & Partin, M. R. (2011). Evaluation of a VHA collaborative to improve follow-up after a positive colorectal cancer screening test. Medical Care, 49(10), 897–903.CrossRefPubMedGoogle Scholar
  10. 10.
    Etzioni, D. A., Yano, E. M., Rubenstein, L. V., Lee, M. L., Ko, C. Y., Brook, R. H., et al. (2006). Measuring the quality of colorectal cancer screening: The importance of follow-up. Diseases of the Colon and Rectum, 49(7), 1002–1010.CrossRefPubMedGoogle Scholar
  11. 11.
    Powell, A. A., Gravely, A. A., Ordin, D. L., Schlosser, J. E., & Partin, M. R. (2009). Timely follow-up of positive fecal occult blood tests strategies associated with improvement. American Journal of Preventive Medicine, 37(2), 87–93.CrossRefPubMedGoogle Scholar
  12. 12.
    Partin, M. R., Burgess, D. J., Burgess, J. F, Jr, Gravely, A., Haggstrom, D., Lillie, S. E., et al. (2015). Organizational predictors of colonoscopy follow-up for positive fecal occult blood test results: An observational study. Cancer Epidemiology Biomarkers & Prevention, 24(2), 422–434.CrossRefGoogle Scholar
  13. 13.
    Partin, M. R., Gravely, A., Gellad, Z. F., Nugent, S., Burgess, J. F., Shaukat, A., et al. (2016). Factors associated with missed and cancelled colonoscopy appointments at Veterans Health Administration facilities. Clinical Gastroenterology and Hepatology, 14(2), 259–267.CrossRefPubMedGoogle Scholar
  14. 14.
    Virginia Garcia Memorial Health Center. (2014). Funding & patient demographics. Accessed 24 Sept 2014.
  15. 15.
    Lieberman, D. A., Rex, D. K., Winawer, S. J., Giardiello, F. M., Johnson, D. A., & Levin, T. R. (2012). Guidelines for colonoscopy surveillance after screening and polypectomy: A consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology, 143(3), 844–857.CrossRefPubMedGoogle Scholar
  16. 16.
    Baron, R. M., & Kenny, D. A. (1986). The moderator-mediator variable distinction in social psychological research: Conceptual, strategic, and statistical considerations. Journal of Personality and Social Psychology, 51(6), 1173–1182.CrossRefPubMedGoogle Scholar
  17. 17.
    Kleinbaum, D., Lawrence, K., Nizam, A., & Muller, K. (2008). Applied regression analysis and other applied multivariable analysis (4th ed.). Australia, Belmont, CA: Brooks/Cole.Google Scholar
  18. 18.
    Hillyer, G. C., Schmitt, K. M., Freedberg, D. E., Kramer, R. A., Su, Y., Rosenberg, R. M., et al. (2014). Fecal-based colorectal cancer screening among the uninsured in northern Manhattan. American Journal of Preventive Medicine, 47(2), 182–187.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    LoConte, N. K., Weeth-Feinstein, L., Conlon, A., & Scott, S. (2013). Engaging health systems to increase colorectal cancer screening: Community-clinical outreach in underserved areas of Wisconsin. Preventing Chronic Disease, 10, E192.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Levy, B. T., Daly, J. M., Luxon, B., Merchant, M. L., Xu, Y., Levitz, C. E., et al. (2010). The “Iowa get screened” colon cancer screening program. Journal of Primary Care & Community Health, 1(1), 43–49.CrossRefGoogle Scholar
  21. 21.
    Carlson, C. M., Kirby, K. A., Casadei, M. A., Partin, M. R., Kistler, C. E., & Walter, L. C. (2011). Lack of follow-up after fecal occult blood testing in older adults: Inappropriate screening or failure to follow up? Archives of Internal Medicine, 171(3), 249–256.CrossRefPubMedGoogle Scholar
  22. 22.
    Dupont-Lucas, C., Dejardin, O., Dancourt, V., Launay, L., Launoy, G., & Guittet, L. (2011). Socio-geographical determinants of colonoscopy uptake after faecal occult blood test. Digestive and Liver Disease, 43(9), 714–720.CrossRefPubMedGoogle Scholar
  23. 23.
    Ferrat, E., Le Breton, J., Veerabudun, K., Bercier, S., Brixi, Z., Khoshnood, B., et al. (2013). Colorectal cancer screening: Factors associated with colonoscopy after a positive faecal occult blood test. British Journal of Cancer, 109(6), 1437–1444.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Mansouri, D., McMillan, D. C., Grant, Y., Crighton, E. M., & Horgan, P. G. (2013). The impact of age, sex and socioeconomic deprivation on outcomes in a colorectal cancer screening programme. PLoS ONE, 8(6), e66063.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Fisher, D. A., Jeffreys, A., Coffman, C. J., & Fasanella, K. (2006). Barriers to full colon evaluation for a positive fecal occult blood test. Cancer Epidemiology Biomarkers & Prevention, 15(6), 1232–1235.CrossRefGoogle Scholar
  26. 26.
    Choi, K. S., Lee, H. Y., Jun, J. K., Shin, A., & Park, E. C. (2012). Adherence to follow-up after a positive fecal occult blood test in an organized colorectal cancer screening program in Korea, 2004–2008. Journal of Gastroenterology and Hepatology, 27(6), 1070–1077.CrossRefPubMedGoogle Scholar
  27. 27.
    Morris, S., Baio, G., Kendall, E., von Wagner, C., Wardle, J., Atkin, W., et al. (2012). Socioeconomic variation in uptake of colonoscopy following a positive faecal occult blood test result: A retrospective analysis of the NHS Bowel Cancer Screening Programme. British Journal of Cancer, 107(5), 765–771.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Miglioretti, D. L., Rutter, C. M., Bradford, S. C., Zauber, A. G., Kessler, L. G., Feuer, E. J., et al. (2008). Improvement in the diagnostic evaluation of a positive fecal occult blood test in an integrated health care organization. Medical Care, 46(9 Suppl 1), S91–S96.CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Percac-Lima, S., Grant, R. W., Green, A. R., Ashburner, J. M., Gamba, G., Oo, S., et al. (2009). A culturally tailored navigator program for colorectal cancer screening in a community health center: A randomized, controlled trial. Journal of General Internal Medicine, 24(2), 211–217.CrossRefPubMedGoogle Scholar
  30. 30.
    Percac-Lima, S., Benner, C. S., Lui, R., Aldrich, L. S., Oo, S. A., Regan, N., et al. (2013). The impact of a culturally tailored patient navigator program on cervical cancer prevention in Latina women. Journal of Women’s Health (Larchmt), 22(5), 426–431.CrossRefGoogle Scholar
  31. 31.
    Coronado, G. D., Schneider, J. L., Sanchez, J. J., Petrik, A. F., & Green, B. (2015). Reasons for non-response to a direct-mailed FIT kit program: Lessons learned from a pragmatic colorectal-cancer screening study in a federally sponsored health center. Translational Behavioral Medicine, 5(1), 60–67.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  • Ann Oluloro
    • 1
    • 2
    Email author
  • Amanda F. Petrik
    • 1
  • Ann Turner
    • 3
  • Tanya Kapka
    • 1
    • 3
  • Jennifer Rivelli
    • 1
  • Patricia A. Carney
    • 2
  • Somnath Saha
    • 2
    • 4
  • Gloria D. Coronado
    • 1
  1. 1.Kaiser Permanente Northwest, Center for Health ResearchPortlandUSA
  2. 2.Oregon Health & Sciences UniversityPortlandUSA
  3. 3.Virginia Garcia Memorial Health CenterHillsboroUSA
  4. 4.Section of General Internal MedicinePortland VA Medical CenterPortlandUSA

Personalised recommendations